Navigation Links
British Authorities Seize Spurious Drugs

Lipitor accounts for worldwide sales of more than $10 billion. The drug is prescribed to patients diagnosed as having an increased risk of cardiovascular// disease and diabetes and those with angina and high blood pressure.

Recently while conducting raids at some wholesale locations British authorities unearthed spurious packets of Pfizer's blockbuster cholesterol drug Lipitor . Officials are also contacting 20,000 pharmacy (retailers and wholesalers) in the country and is recalling all that remains of a 120,000-packet batch 004405K1. Each packet containing 28 x 20mg pills.

The seized packets were tested in a lab and were found to be fake, containing a different statin not currently marketed in Britain. It is not sure how many patients would have taken the fake drug and of its impact however it is said that there is no immediate risk to the health of the individuals.

Pfizer officials reacted to the seizure saying, it is alarmed at the discovery and that the drugs would have reached Britain through parallel trade, whereby drugs are shipped around Europe to exploit price differences. The company urged for new measures like outlawing the repackaging of original manufacturers' medicines and introduction of tamper-resistant medicine packaging and standardised European bar code for medicines.

The head of the intelligence agency in UK has said that UK's supply chain is one of the most difficult to penetrate because of the safeguards that are in place. However they say that they will continue to maintain such vigilance and keep improving their anti-counterfeit methods to protect the public and stay ahead of the criminals.

'"/>




Page: 1

Related medicine news :

1. Designer baby for British couple
2. Collaborations planned between British Organization and Indian health care industry
3. British Healthcare Mission Explores Partnership Possibilities With Indian Healthcare Sector
4. British Women Flies to India for Treatment of Breast Cancer
5. Sharp Increase In Morning-After Pill Sales Among British Women
6. British company developing ‘Safer Cigarettes
7. British man Recovered from HIV
8. British medical education suffers shortage of bodies
9. Relief For British MS Patients: Cannabis-Based Oral Spray
10. British Scientists Doubt Delhi Doctor’s Stem Cell Claim
11. British Grandmother has timely bypass surgery in India
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... New York, NY (PRWEB) , ... April 28, ... ... Shiel Medical Laboratory to expanded distribution of the GlycoMark test throughout the Northeast ... indicates recent hyperglycemia in patients with diabetes. The GlycoMark test provides a clinically ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America proudly ... offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start and ... These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic Back Surgery and ... revolutionary endoscopic practice under Dr. Datta. Patel is a Board Certified Anesthesiologist, with ... revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is unlike traditional back ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... The Texas ... in recently to the labor and delivery team at Women’s Hospital at Renaissance in ... who give birth at the hospital and decide to donate. , “Women’s Hospital ...
(Date:4/28/2017)... , ... April 28, 2017 , ... ... hERG liability could substantially improve drug safety and minimize the cost of development. ... validating ion channel inhibition using cell lines and for cardiac toxicity using induced ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
(Date:4/19/2017)... - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that ... Conference 2017 at the Sheraton Hotel in Toronto, Ontario ... of the Company is scheduled to present on Tuesday, May 2 ... the Chairman of the Board, Tony Holler will also ... For more ...
Breaking Medicine Technology: